
PURPOSE:The purpose of the Nominating and Governance Committee (the "Nominating Committee) of the Board of Directors (the "Board") of Trubion Pharmaceuticals, Inc. (the "Company") is to ensure that the Board is properly constituted to meet its fiduciary obligations to stockholders and the Company and that the Company has and follows appropriate governance standards. To carry out this purpose, the Nominating and Governance Committee shall: (1) assist the Board by identifying prospective director nominees and by recommending to the Board the director nominees for the next annual meeting of stockholders; (2) recommend to the Board director nominees for each Committee of the Board, (3) develop and recommend to the Board the corporate governance principles applicable to the Company; and (4) provide oversight with respect to corporate governance.

COMMITTEE MEMBERSHIP AND ORGANIZATION:The Nominating Committee will be appointed by, and will serve at the discretion of, the Board. The Nominating Committee shall consist of at least three members of the Board. As and when required , the members of the Nominating Committee shall meet the independence requirements as defined under applicable NASDAQ and Securities and Exchange Commission (the "SEC") rules.

COMMITTEE RESPONSIBILITIES AND AUTHORITY:The Nominating Committee shall:

MEETINGS:It is anticipated that the Nominating Committee will meet at least twice per year. The Nominating Committee may establish its own schedule, which it will provide to the Board in advance.

MINUTES:The Nominating Committee will maintain written minutes of its meetings, which minutes will be filed with the minutes of the meetings of the Board.

REPORTS:In addition to preparing the any report required in the Company's Proxy Statement in accordance with the rules and regulations of the SEC, the Nominating Committee will summarize its examinations and recommendations to the Board as may be appropriate, consistent with the Nominating Committee's Charter.

COMPENSATION:Members of the Nominating Committee shall receive such fees, if any, for their service as Nominating Committee members as may be determined by the Board in its sole discretion. Such fees may include retainers or per meeting fees. Fees may be paid in such form of consideration as is determined by the Board, consistent with applicable law.

AUTHORITYBy adopting this Charter, the Board delegates to the Nominating Committee full authority in its discretion to:

DELEGATION OF AUTHORITYThe Nominating Committee may delegate such of its authority and responsibilities as the Nominating Committee deems proper to members of the Nominating Committee or a subcommittee, consistent with applicable law.

Samuel R. Saks M.D.
Patrick J. Heron
David Schnell M.D.
Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

